Cargando…

Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems

Chronic kidney disease is often characterized by enhanced activity of the renin–angiotensin system (RAS) and the sympathetic nervous system. Independent of their effect on blood pressure, these systems also contribute to the pathogenesis of both structural and functional cardiovascular abnormalities...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blankestijn, Peter J, London, Gerard, Fliser, Danilo, Jager, Kitty J, Lindholm, Bengt, Goldsmith, David, Wiecek, Andrzej, Suleymanlar, Gultekin, Agarwal, Rajiv, Ortiz, Alberto, Massy, Ziad, Martinez-Castelao, Alberto, Covic, Adrian, Dekker, Friedo W, Zoccali, Carmine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089777/ https://www.ncbi.nlm.nih.gov/pubmed/25018897 http://dx.doi.org/10.1038/kisup.2011.3

Ejemplares similares

The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?
por: Agarwal, Rajiv, et al.
Publicado: (2011)

Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease
por: London, Gerard, et al.
Publicado: (2011)

Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?
por: Jager, Kitty J, et al.
Publicado: (2011)

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
por: Fliser, Danilo, et al.
Publicado: (2011)

The complexity of the cardio–renal link: taxonomy, syndromes, and diseases
por: Zoccali, Carmine, et al.
Publicado: (2011)

Promoting scientific collaboration and education in cardiovascular–renal medicine: EURECAM: An ERA-EDTA-based working group
por: Covic, Adrian, et al.
Publicado: (2009)

A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020)

A new methodological series in CKJ: from basic-level methodology to artificial intelligence in medicine
por: Zoccali, Carmine, et al.
Publicado: (2023)

Translational research in nephrology: prognosis
por: Tripepi, Giovanni, et al.
Publicado: (2021)

External validation of prognostic models: what, why, how, when and where?
por: Ramspek, Chava L, et al.
Publicado: (2020)

Where to look for the most frequent biases?
por: Jager, Kitty J., et al.
Publicado: (2020)

Assessing physical activity and function in patients with chronic kidney disease: a narrative review
por: Bakker, Esmée A, et al.
Publicado: (2020)

Points of attention when conducting etiological research
por: Stel, Vianda S., et al.
Publicado: (2021)

An introduction to joint models—applications in nephrology
por: Chesnaye, Nicholas C, et al.
Publicado: (2020)

Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design
por: Trevisan, Marco, et al.
Publicado: (2020)

Appraising prediction research: a guide and meta‐review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST)
por: de Jong, Ype, et al.
Publicado: (2021)

The long-term benefits of early intensive therapy in chronic diseases—the legacy effect
por: Zoccali, Carmine, et al.
Publicado: (2023)

Evidence‐based medicine—When observational studies are better than randomized controlled trials
por: Bosdriesz, Jizzo R., et al.
Publicado: (2020)

Conducting correlation analysis: important limitations and pitfalls
por: Janse, Roemer J, et al.
Publicado: (2021)

An introduction to inverse probability of treatment weighting in observational research
por: Chesnaye, Nicholas C, et al.
Publicado: (2021)

The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council
por: Zoccali, Carmine, et al.
Publicado: (2018)

Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them
por: Fu, Edouard L, et al.
Publicado: (2020)

Rompin' at the Reno /
por: Carter, Benny
Publicado: (1960)

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe
por: Massy, Ziad A, et al.
Publicado: (2019)

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe
por: Massy, Ziad A, et al.
Publicado: (2019)

Patient‐reported outcome measures ( PROMs): making sense of individual PROM scores and changes in PROM scores over time
por: van der Willik, Esmee M., et al.
Publicado: (2020)

Chronic kidney disease and end-stage renal disease—a review produced to contribute to the report ‘the status of health in the European union: towards a healthier Europe’
por: Zoccali, Carmine, et al.
Publicado: (2010)

Funnel plots of patient‐reported outcomes to evaluate health‐care quality: Basic principles, pitfalls and considerations
por: van der Willik, Esmee M., et al.
Publicado: (2020)

The 2007 ERA-EDTA Registry Annual Report—a Précis
por: Stel, Vianda S., et al.
Publicado: (2009)

A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community
por: Sever, Mehmet Şükrü, et al.
Publicado: (2020)

Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis
por: Vejakama, P., et al.
Publicado: (2011)

Gitelman's syndrome with panhypopituitarism: Reno-endocrine interplay
por: Upreti, Vimal, et al.
Publicado: (2012)

Observation of the last, weakest neutrino transformation at RENO
por: Kim, Soo-Bong
Publicado: (2012)

Spontaneous reno-colic fistula in an elderly patient
por: Chawla, A., et al.
Publicado: (2016)

The reno-pineal axis: A novel role for melatonin
por: Kalra, Sanjay, et al.
Publicado: (2012)

Cardiovascular and renal medicine, an expanding territory
por: Zoccali, Carmine, et al.
Publicado: (2011)

Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care
por: Pecoits‐Filho, Roberto, et al.
Publicado: (2019)

The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease
por: Massy, Ziad A, et al.
Publicado: (2021)

Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data
por: Janse, Roemer J, et al.
Publicado: (2022)

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
por: Gansevoort, Ron T., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8fc37s9huoi2hcrmrbq1l9vora